AstraZeneca Goodwill and Intangible Assets 1992-2025 | AZN
AstraZeneca goodwill and intangible assets from 1992 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- AstraZeneca goodwill and intangible assets for the quarter ending June 30, 2025 were $59.147B, a 2.21% decline year-over-year.
- AstraZeneca goodwill and intangible assets for 2024 were $58.202B, a 0.11% increase from 2023.
- AstraZeneca goodwill and intangible assets for 2023 were $58.137B, a 1.67% decline from 2022.
- AstraZeneca goodwill and intangible assets for 2022 were $59.127B, a 5.22% decline from 2021.
| AstraZeneca Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $58,202 |
| 2023 | $58,137 |
| 2022 | $59,127 |
| 2021 | $62,384 |
| 2020 | $32,792 |
| 2019 | $32,501 |
| 2018 | $33,666 |
| 2017 | $38,013 |
| 2016 | $39,244 |
| 2015 | $34,446 |
| 2014 | $32,531 |
| 2013 | $26,028 |
| 2012 | $26,346 |
| 2011 | $20,842 |
| 2010 | $22,029 |
| 2009 | $22,115 |
| 2008 | $22,197 |
| 2007 | $21,351 |
| 2006 | $4,204 |
| 2005 | $2,712 |
| 2004 | $2,826 |
| 2003 | $2,884 |
| 2002 | $2,807 |
| 2001 | $2,700 |
| 2000 | $2,951 |
| 1999 | $3,736 |
| 1998 | $637 |
| 1997 | $133 |
| 1996 | |